Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study

Background: The virological and immunological effects of the immunomodulatory drugs used for COVID-19 remain unknown. We evaluated the impact of interleukin (IL)-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and the antibody response in patients with COVID-19. Methods: Prospective cohort...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mar Masiá, Marta Fernández-González, Sergio Padilla, Piedad Ortega, José A. García, Vanesa Agulló, Javier García-Abellán, Guillermo Telenti, Lucía Guillén, Félix Gutiérrez
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2020-10-01
Serija:	EBioMedicine
Teme:	Tocilizumab SARS-CoV-2 COVID-19 Viral kinetics Antibody responses Anti-cytokine therapy
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2352396420303753
Oznake:	Označite Brez oznak, prvi označite!